Skip to Content
DiagnosticsDiagnostics
  • Correction
  • Open Access

30 March 2026

Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786

,
,
,
and
1
Department of Cardiac Surgery, Upper Silesian Heart Center, 40-635 Katowice, Poland
2
Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-751 Katowice, Poland
3
First Department of Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-635 Katowice, Poland
4
Department of Internal Medicine and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-029 Katowice, Poland
In the original publication [1], the informed consent statement was marked as not applicable. After confirmation with the authors, the correct informed consent statement should be: Informed consent was obtained from all subjects involved in the study.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor, and the original publication has also been updated.

Reference

  1. Bednarek, A.M.; Owczarek, A.J.; Dziadosz, D.; Olszanecka-Glinianowicz, M.; Chudek, J.T. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.